Median symptom duration between onset and emergency presentation was 1 day pre-COVID and 2 days during pandemic, representing a clinically significant difference despite lack of statistical significance.
Hirschsprung's enterocolitis that persists past age 5, or that is unresponsive to typical treatment under age 5, should prompt consideration of Hirschsprung-associated IBD diagnosis.
Patients during COVID-19 had an increased rate of perforation compared to pre-pandemic, stayed in hospital longer, and had increased risks of complications.
Journal of Pediatric Surgery Article Review: May 2023, CAPS Issue
▶Ep 144 · 0:44
quoteSonia Butterworth, I'm a pediatric surgeon at BC Children's Hospital, a clinical professor at UBC, and the chair of the publication committee for the Canadian Association of Pediatric Surgeons.↗
▶Ep 144 · 2:33
clinicalBiologic therapy is most likely to be effective for treating Hirschsprung-associated IBD.↗
▶Ep 144 · 3:18
clinicalHirschsprung's enterocolitis that persists past age 5, or that is unresponsive to typical treatment under age 5, should prompt consideration of Hirschsprung-associated IBD diagnosis.↗
▶Ep 144 · 5:55
epidemiologicalMedian symptom duration between onset and emergency presentation was 1 day pre-COVID and 2 days during pandemic, representing a clinically significant difference despite lack of statistical significance.↗
▶Ep 144 · 6:56
epidemiologicalPatients during COVID-19 had an increased rate of perforation compared to pre-pandemic, stayed in hospital longer, and had increased risks of complications.↗
▶Ep 144 · 9:10
opinionEven the pre-protocol time of 73 minutes for button battery removal was a very impressive target.↗
Sonia's statements about Hirschsprung disease6 statements
Journal of Pediatric Surgery Article Review: May 2023, CAPS Issue
▶Ep 60 · 0:44
quoteSonia Butterworth, I'm a pediatric surgeon at BC Children's Hospital, a clinical professor at UBC, and the chair of the publication committee for the Canadian Association of Pediatric Surgeons.↗
▶Ep 60 · 2:33
clinicalBiologic therapy is most likely to be effective for treating Hirschsprung-associated IBD.↗
▶Ep 60 · 3:18
clinicalHirschsprung's enterocolitis that persists past age 5, or that is unresponsive to typical treatment under age 5, should prompt consideration of Hirschsprung-associated IBD diagnosis.↗
▶Ep 60 · 5:55
epidemiologicalMedian symptom duration between onset and emergency presentation was 1 day pre-COVID and 2 days during pandemic, representing a clinically significant difference despite lack of statistical significance.↗
▶Ep 60 · 6:56
epidemiologicalPatients during COVID-19 had an increased rate of perforation compared to pre-pandemic, stayed in hospital longer, and had increased risks of complications.↗
▶Ep 60 · 9:10
opinionEven the pre-protocol time of 73 minutes for button battery removal was a very impressive target.↗
Sonia's statements about Inflammatory Bowel Disease6 statements
Journal of Pediatric Surgery Article Review: May 2023, CAPS Issue
▶Ep 4 · 0:44
quoteSonia Butterworth, I'm a pediatric surgeon at BC Children's Hospital, a clinical professor at UBC, and the chair of the publication committee for the Canadian Association of Pediatric Surgeons.↗
▶Ep 4 · 2:33
clinicalBiologic therapy is most likely to be effective for treating Hirschsprung-associated IBD.↗
▶Ep 4 · 3:18
clinicalHirschsprung's enterocolitis that persists past age 5, or that is unresponsive to typical treatment under age 5, should prompt consideration of Hirschsprung-associated IBD diagnosis.↗
▶Ep 4 · 5:55
epidemiologicalMedian symptom duration between onset and emergency presentation was 1 day pre-COVID and 2 days during pandemic, representing a clinically significant difference despite lack of statistical significance.↗
▶Ep 4 · 6:56
epidemiologicalPatients during COVID-19 had an increased rate of perforation compared to pre-pandemic, stayed in hospital longer, and had increased risks of complications.↗
▶Ep 4 · 9:10
opinionEven the pre-protocol time of 73 minutes for button battery removal was a very impressive target.↗
